This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université de Montréal directory, so their courses and email address may be missing. Find their university profile.
Research
Latest papers
A high-performance hydrogel platform enabling dual anti-miR-21 and TGF-β1 delivery to improve arterial plaque stability and enhance therapeutic angiogenesis outcomes.
Scientific reports · 2026 · senior author
Comparing innovative artificial intelligence algorithms to assess echocardiographic videos for clinical modeling.
The Journal of thoracic and cardiovascular surgery · 2025
In Vitro and In Vivo Interventions Reveal the Health Benefits of Levan-Type Exopolysaccharide Produced by a Fish Gut Isolate Lactobacillus reuteri FW2.
Life (Basel, Switzerland) · 2025
Latest funding
- $8,000
Mechanisms in the pathogenesis of chronic inflammatory bowel diseases involving interactions between diet and gut microbial flora
CIHR · 2012 · Principal investigator
From the 150 most recent of 153 publications.
A high-performance hydrogel platform enabling dual anti-miR-21 and TGF-β1 delivery to improve arterial plaque stability and enhance therapeutic angiogenesis outcomes.
Islam P, Abosalha A, Schaly S, Boyajian JL, Kassab A, Makhlouf S, Santos M, Renesteen E, Shum-Tim C, Pal A, Shum-Tim D, Prakash S
Comparing innovative artificial intelligence algorithms to assess echocardiographic videos for clinical modeling.
Laldin S, Shum-Tim C, Prakash S, Shum-Tim D
In Vitro and In Vivo Interventions Reveal the Health Benefits of Levan-Type Exopolysaccharide Produced by a Fish Gut Isolate Lactobacillus reuteri FW2.
Ahmad W, Nasir A, Prakash S, Hayat A, Rehman MU, Khaliq S, Akhtar K, Anwar MA, Munawar N
Drug Discovery in the Age of Artificial Intelligence: Transformative Target-Based Approaches.
Patne AY, Dhulipala SM, Lawless W, Prakash S, Mohapatra SS, Mohapatra S
Baculovirus Expressing Tumor Growth Factor-β1 (TGFβ1) Nanoshuttle Augments Therapeutic Effects for Vascular Wound Healing: Design and In Vitro Analysis.
Islam P, Abosalha A, Schaly S, Boyajian JL, Santos M, Makhlouf S, Renesteen E, Kassab A, Shum-Tim C, Shum-Tim D, Prakash S
Colon-Targeted Sustained-Release Combinatorial 5-Fluorouracil and Quercetin poly(lactic-co-glycolic) Acid (PLGA) Nanoparticles Show Enhanced Apoptosis and Minimal Tumor Drug Resistance for Their Potential Use in Colon Cancer.
Abosalha AK, Islam P, Boyajian JL, Thareja R, Schaly S, Kassab A, Makhlouf S, Alali S, Prakash S
The impact and future of artificial intelligence in medical genetics and molecular medicine: an ongoing revolution.
Ozcelik F, Dundar MS, Yildirim AB, Henehan G, Vicente O, Sánchez-Alcázar JA, Gokce N, Yildirim DT, Bingol NN, Karanfilska DP, Bertelli M, Pojskic L, Ercan M, Kellermayer M, Sahin IO, Greiner-Tollersrud OK, Tan B, Martin D, Marks R, Prakash S, Yakubi M, Beccari T, Lal R, Temel SG, Fournier I, Ergoren MC, Mechler A, Salzet M, Maffia M, Danalev D, Sun Q, Nei L, Matulis D, Tapaloaga D, Janecke A, Bown J, Cruz KS, Radecka I, Ozturk C, Nalbantoglu OU, Sag SO, Ko K, Arngrimsson R, Belo I, Akalin H, Dundar M
Probiotics, prebiotics, synbiotics and other microbiome-based innovative therapeutics to mitigate obesity and enhance longevity via the gut-brain axis.
Boyajian JL, Islam P, Abosalha A, Schaly S, Thareja R, Kassab A, Arora K, Santos M, Shum-Tim C, Prakash S
Nanotechnology in development of next generation of stent and related medical devices: Current and future aspects.
Islam P, Schaly S, Abosalha AK, Boyajian J, Thareja R, Ahmad W, Shum-Tim D, Prakash S
Controlled and customizable baculovirus NOS3 gene delivery using PVA-based hydrogel systems.
Schaly S, Islam P, Boyajian JL, Thareja R, Abosalha A, Arora K, Shum-Tim D, Prakash S
Mechanisms in the pathogenesis of chronic inflammatory bowel diseases involving interactions between diet and gut microbial flora
Principal investigators: Levy, Emile; Ahmad, Ali; Amre, Devendra; Prakash, Satya
Keywords: Crohn'S Disease; Epigenetics; Gut Microbial Flora; Inflammation; Inflammatory Bowel Diseases; Metabolome; Nutrigenenomics; Nutrition; Oxidative Stress; Probiotics
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Satya Prakash and Satya Prakash: 153 shared papers
- Satya Prakash and Anie Philip: 3 shared papers
- Anie Philip and Satya Prakash: 3 shared papers
- Devendra Amre and Satya Prakash: 2 shared papers
- Devendra Amre and Satya Prakash: 2 shared papers
- Satya Prakash and Maryam Tabrizian: 2 shared papers
- Maryam Tabrizian and Satya Prakash: 2 shared papers
- Satya Prakash and Adel Schwertani: 1 shared paper
- Satya Prakash and Amine Kamen: 1 shared paper
- Adel Schwertani and Satya Prakash: 1 shared paper
- Amine Kamen and Satya Prakash: 1 shared paper
- Biomedical Engineering
- Surgery
- Medicine/Cardiology
- Bioengineering
- Other
Co-authors at Université de Montréal, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Satya Prakash
Biomedical Engineering
153 shared papers, latest 2026
Anie Philip
Surgery
3 shared papers, latest 2013
Maryam Tabrizian
Biomedical Engineering
2 shared papers, latest 2013
Devendra Amre
Faculty
2 shared papers, latest 2006
Adel Schwertani
Medicine/Cardiology
1 shared papers, latest 2014
Amine Kamen
Bioengineering
1 shared papers, latest 2012
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.